Tg Therapeutics (TGTX) FCF Margin (QoQ) (2017 - 2026)
Tg Therapeutics (TGTX) FCF Margin (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tg Therapeutics | 8.88 Bn | 8.80 Bn | 171.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,893.00 |
| Dec 31, 2025 | 2,454.00 |
| Sep 30, 2025 | -1,961.00 |
| Jun 30, 2025 | 2,902.00 |
| Mar 31, 2025 | -6.00 |
| Dec 31, 2024 | -914.00 |
| Sep 30, 2024 | -2,211.00 |
| Jun 30, 2024 | 2,047.00 |
| Mar 31, 2024 | 1,711.00 |
| Dec 31, 2023 | -8,052.00 |
| Sep 30, 2023 | 31,180.00 |
| Jun 30, 2023 | 50,636.00 |
| Mar 31, 2023 | 2.91 Mn |
| Dec 31, 2022 | 685,981.00 |
| Sep 30, 2022 | -2.84 Mn |
| Jun 30, 2022 | -486,115.00 |
| Mar 31, 2022 | 34,037.00 |
| Dec 31, 2021 | -43,362.00 |
| Sep 30, 2021 | 59,147.00 |
| Jun 30, 2021 | 636,183.00 |